反応式
[C:1]([O:10]C1C=CC=CC=1)(=O)[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4].[NH2:17][C:18]1[CH:23]=[CH:22][C:21]([O:24][CH3:25])=[CH:20][CH:19]=1>>[CH3:25][O:24][C:21]1[CH:22]=[CH:23][C:18]([NH:17][C:1](=[O:10])[C:2]2[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=2)[OH:4])=[CH:19][CH:20]=1参加物
3
実験手順
The 4′-methoxy-salicylanilide was prepared by condensing phenyl salicylate with 4-aminoanisole then purified as described in Example 2a. The mixture of ligands was then prepared from 4′-methoxy-salicylanilide and 1,1′-bi-2-naphthol using the procedure described in Example 5a. 31P NMR (121.77 MHz): several peaks between 116-118 ppm.
後処理
- customthen purified
- additionThe mixture of ligands
- customwas then prepared from 4′-methoxy-salicylanilide and 1,1′-bi-2-naphthol using the procedure
出典と根拠
- ORDレコード
- ord-2fd168cee4a14c97a4b946f0e3f1930d
- 出典データセット
- uspto-grants-2003_12
- 特許番号
- US06664427B1
関連ノート
読み込み中…